9. Cyclin-Dependent kinase inhibitor as a potential novel therapeutic agent for pancreatic cancer

Angela Chou; Anthony J. Gill; Jian Jian Kang; Christine Lee; Marcelo Sergio; Apgi; Liz Musgrove; Adrienne Morey; Sean M. Grimmond; Andrew V. Biankin; Marina Pajic

doi:10.1097/01.pat.0000443699.20071.3b

Related publications

Article2005

Subcellular Localization and Protein Levels of Cyclin-Dependent Kinase Inhibitor p27 Independently Predict for Survival in Epithelial Ovarian Cancer

Amanda Psyrri, A. Bamias, Ziwei Yu, Paul Weinberger, Mohamad Kassar, S. Markakis, Diane Kowalski, Eleni Efstathiou, Robert L. Camp, David L. Rimm, Meletios A Dimopoulos

Article2021

Small-Molecule Inhibitor Targeting Protein Kinase D: A Potential Therapeutic Strategy

Die Lv, Hongli Chen, Yun Feng, Bomiao Cui, Yingzhu Kang, Ping Zhang, Min Luo, Jiao Chen

Frontiers in Oncology

Article2022

Cell cycle involvement in cancer therapy; WEE1 kinase, a potential target as therapeutic strategy

Sajjad Vakili‐Samiani, Omid Joodi Khanghah, Elham Gholipour, Fatemeh Najafi, Elham Zeinalzadeh, Parisa Samadi, Parisa Sarvarian, Shiva Pourvahdani, Shohre Karimi Kelaye, Michael R Hamblin, Abbas Ali Hosseinpour Feizi

Article2019

Oxidative phosphorylation as a potential therapeutic target for cancer therapy

Valentina Sica, José Manuel Bravo‐San Pedro, Gautier Stoll, Guido Guido Kroemer

Article2020

Discovery of Hordenine as a Potential Inhibitor of Pyruvate Dehydrogenase Kinase 3: Implication in Lung Cancer Therapy

Saleha Anwar, Taj Mohammad, Anas Shamsi, Aarfa Queen, Shahnaz Parveen, Suaib Luqman, Gulam Mustafa Hasan, Khalid A. Alamry, Naved Azum, Abdullah Mohamed Asiri, Md. Imtaiyaz Hassan